IP Verse

Galenicum Health S.l.u. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Galenicum Health S.l.u.

Patent Number:
EP3634463
Title:
Improved Protocol For Treatment Of Lupus Nephritis
Applicant:
AURINIA PHARMACEUTICALS INC.
Opposition Date:
Jun 27, 2024
Patent Number:
EP3810201
Title:
Gip/Glp1 Agonist Compositions
Applicant:
ELI LILLY AND COMPANY
Opposition Date:
Mar 7, 2024
Patent Number:
EP2508188
Title:
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate
Applicant:
ASTRAZENECA AB
Opposition Date:
Feb 9, 2024
Patent Number:
EP3191461
Title:
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole
Applicant:
PFIZER INC.
Opposition Date:
Aug 3, 2022
Patent Number:
EP2863895
Title:
Tablet Formulation Comprising A Peptide And A Delivery Agent
Applicant:
NOVO NORDISK A/S
Opposition Date:
Jan 14, 2022
Patent Number:
EP3431475
Title:
Solid Forms Of A Selective Cdk4/6 Inhibitor
Applicant:
PFIZER INC.
Opposition Date:
Jan 7, 2022
Patent Number:
EP2797581
Title:
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione
Applicant:
AMGEN (EUROPE) GMBH
Opposition Date:
Feb 8, 2021
Patent Number:
EP2866825
Title:
Use Of Long-Acting Glp-1 Peptides
Applicant:
NOVO NORDISK A/S
Opposition Date:
Jan 8, 2021
Patent Number:
EP2139494
Title:
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate
Applicant:
ASTRAZENECA AB
Opposition Date:
Dec 11, 2020
Patent Number:
EP3326620
Title:
Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2- Hydroxybenzoyl)Amino)Caprylic Acid
Applicant:
NOVO NORDISK A/S
Opposition Date:
Dec 4, 2020

Latest patents of Galenicum Health S.l.u. opposed by its competitors

Patent:
EP3512505
Grant Date:
Mar 15, 2023
Title:
Vildagliptin Pharmaceutical Compositions
Oppositions:
2
Patent:
EP3240529
Grant Date:
Feb 2, 2022
Title:
Stable Pharmaceutical Compositions Comprising Micafungin
Oppositions:
2
Patent:
EP2915526
Grant Date:
Jun 2, 2021
Title:
Pharmaceutical Compositions Comprising Anagrelide
Oppositions:
1
Patent:
EP3102187
Grant Date:
Mar 25, 2020
Title:
Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets
Oppositions:
7

Competitors of Galenicum Health S.l.u.

NOVO NORDISK A/S

PFIZER INC.

AMGEN (EUROPE) GMBH

Want to track Galenicum Health S.l.u.?

Feel free to send us a message here and we will get back to you